

Author: Hakobyan Liana Haaijer-Ruskamp Flora M. > Dobre Daniela Denig Petra
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.34, Iss.12, 2011-12, pp. : 1191-1202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Post-hoc analysis confirms abatacept's activity in SLE
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :





